Crispr-Edited Pancreatic Cells Successfully Transplanted in Type 1 Diabetes Patient for the First Time

Summary

For the first time, researchers have successfully implanted Crispr-edited pancreatic cells into a patient with type 1 diabetes. The gene-edited cells produced insulin for months without requiring immunosuppressants, marking a significant milestone in using Crispr technology to potentially cure global diseases like diabetes.